Indications of Prandin
Prandin used to treat type 2 diabetes (a condition in which the body does not use insulin, usually, and therefore cannot control the amount of blood sugar). Prandin helps the body to regulate the amount of glucose (sugar) in the blood. This reduces the amount of glucose by stimulating the pancreas to release insulin.
Prandin reduces your chances of heart attack, stroke or other complications of diabetes, associated with such as kidney failure, nerve damage (numbness, cold legs or feet, decreased sexual ability in men and women), vision problems.
Side effects of Prandin
Symptoms of hypoglycaemia (sweating, tremor, dizziness, increased appetite, palpitations, nausea, weakness, malaise); transient slight increase in activity of «liver» enzymes in the blood; allergic reactions (rash, pruritus, urticaria) Overdose. Symptoms may be possible worsening of hypoglycemia with clinical manifestations of varying severity. Treatment: moderate — the appointment of dextrose / sugar solution into the correction dose and / or meals; while severe hypoglycemia accompanied by neurological symptoms (coma, convulsions), — in / in a dextrose solution, symptomatic therapy. Hemodialysis is inefficient due to the high binding of the drug with plasma proteins.
Before the drug can be observed changes in blood sugar levels. This entails:
dizziness or lightheadedness
nervousness or irritability
sudden changes in behavior or mood
numbness or tingling around the mouth
If hypoglycemia is not treated, severe symptoms may develop. Then there are:
loss of consciousness
The most common side effects are
Tell your doctor if you have any of these symptoms.
Low hypoglycemic activity (comparable to acarbose), with starliks loses in efficiency novonormu. Monotherapy Glinides to reduce HbA1C content of about 0.5-0.8%.
Glinides have the same risk of weight gain as the sulfonylureas (approximately 2 kg).
After some time, there may be a decrease in the efficiency Glinides.
Prandin used in an initial dose of 0.5 mg before a meal 15-30 minutes three times a day. Increasing the dose is carried out not earlier than 2 weeks after initiation of treatment, focusing on blood glucose levels. The maximum single dose — 4 mg daily — 16 mg.